Name Lunginnov
DescriptionLunginnov s.a.s develops, manufacture and commercialize innovative solutions to study or diagnose endothelial dysfunction (sepsis, cancer, etc…)
Principal Missions:
1) To develop, produce and commercialize innovative biomarkers (tissue and blood), in order to detect, to study, to diagnose endothelial dysfunction (active, inflammatory or injured) and/or to track changes in treatments.
2) To develop, produce and commercialize reagents (research use only/RUO) products that have been validated by peer-reviewed publications.
Complementary Mission: To develop R&D programs in order to offer new diagnostic and therapeutic solutions targeting the endothelium.
Lunginnov s.a.s offers two ranges of products:
1)Products « for research use only » purposes (antibodies, recombinant proteins, kits / immunoassays…) to study vascular remodeling (cancer, angiogenesis, inflammation, sepsis, obesity…).
2) IVD products including ELISA kits for diagnosis and/or prognosis and/or the follow-up of patients under treatment in domains of sepsis and cancer.
LocationLille, France
Web pagehttp://www.lunginnov.com
Contact informationcommercial@lunginnov.com
Address : Lunginnov
1, rue du Pr Calmette
Institut Pasteur
59000 Lille
France
Tel : 33 320 877 211
Fax : 33 320 877 884
# Antibodies13
Usersmdelehedde@lunginnov.com